|
Originally published In Press as doi:10.1074/jbc.M104966200 on October 4, 2001
J. Biol. Chem., Vol. 276, Issue 49, 45988-45995, December 7, 2001
The Human Protein HSPC021 Interacts with Int-6 and Is
Associated with Eukaryotic Translation Initiation Factor 3*
Christelle
Morris-Desbois §,
Stéphane
Réty §,
Myriam
Ferro¶,
Jérôme
Garin¶, and
Pierre
Jalinot
From the Laboratoire de Biologie Moléculaire et
Cellulaire, UMR 5665 CNRS-ENSL, 46 Allée d'Italie, 69364 Lyon
Cedex 07, France and ¶ Laboratoire de Chimie des Protéines,
Commissariat à l'Energie Atomique/Grenoble, 17 rue des Martyrs,
38054 Grenoble Cedex, France
Received for publication, May 30, 2001, and in revised form, October 1, 2001
 |
ABSTRACT |
The Int-6 protein has been shown to be a subunit
of eukaryotic translation initiation factor 3 (eIF3) and to play
a role in the control of cell growth. By immunoprecipitation
experiments and mass spectrometry analyses, we identified a human
protein previously known as HSPC021 that is associated with Int-6.
Exposure of Jurkat cells to the phosphatase inhibitor
H2O2 triggers a marked phosphorylation on
tyrosine of HSPC021. Several experiments were performed to evaluate
whether this protein is associated with eIF3. It was observed that
HSPC021 coelutes with Int-6 and eIF3 in gel filtration,
coimmunoprecipitates with eIF3, and is incorporated into eIF3 both in
rabbit reticulocyte lysates and in COS7 cells. A direct protein-protein
interaction occurs between HSPC021 and Int-6, but the analysis of
different mutants of HSPC021 indicated that a larger region of the
protein is necessary for incorporation into eIF3 as compared with
binding to Int-6. Taken together, our results establish that HSPC021 is
tightly associated with the mammalian translation initiation factor
eIF3. Analysis of the primary sequence of HSPC021 from different
species revealed the presence of a tetratricopeptide repeat, a
proteasome-COP9 (constitutive photomorphogenesis 9) signalosome-initiation
factor 3 domain along with a Pumilio FBF repeat. These protein
motifs are also present in subunits of eIF3, of the lid of the 26 S
proteasome, and of the COP9 signalosome.
 |
INTRODUCTION |
The Int-6 protein has been identified by three independent
approaches. Studies in mice infected by the mouse mammary tumor virus
have shown that the int-6 gene is a common site of
integration of the provirus in preneoplastic and neoplastic mammary
lesions (1). This integration within the gene causes production of truncated transcripts. Hence, either loss of expression of the modified
allele or production of shortened forms of the protein alters control
of cell growth. The human cDNA coding for Int-6 was isolated in a
two-hybrid screen using the Tax transforming protein of human T-cell
leukemia virus type 1 as bait (2). Finally, the Int-6 protein was
characterized as a subunit of the translation initiation factor eIF3
(3).1 This factor represents
a complex assembly of various subunits of which 10 have already been
cloned for the mammalian factor: p170, p116, p110, p66, Int-6/p48, p47,
p44 (also known as p42), p40, p36, and p35 (3-9). The eIF3 factor
plays a central role in translation initiation by maintaining the 40 S
ribosomal subunit dissociated from the 60 S and by promoting the
association of the former with mRNA and initiator Met-tRNA (10).
This complex establishes multiple protein-protein interactions with
other translation initiation factors. For example, it has been shown
that eIF3 contacts eIF5 and eIF1 (8, 11, 12) and that it binds
cooperatively with eIF4A to the central domain of eIF4G-1 (13).
Recently, Asano et al. (14) have shown the existence of a
complex including the yeast initiation factors eIF1, eIF2, eIF3, eIF5
and initiator Met-tRNA. The presence of Int-6 in eIF3 purified from
various organisms is now well established (3, 15-17), but several
observations show that Int-6 is also present in other cellular protein
complexes. Int-6 includes both a nuclear export signal at its N
terminus and a nuclear localization signal, suggesting that the protein shuttles between nucleus and cytoplasm (18). In agreement with this
notion, endogenous Int-6 of primary lymphocytes has been observed in
the nuclear compartment, partly associated with the nuclear bodies
containing the promyelocytic leukemia protein (19). This localization
is related to the ability of Int-6 to interact with the Ret finger
protein (19) that binds to promyelocytic leukemia protein (20). A
nuclear localization of Int-6 has also been observed in the plant
Arabidopsis thaliana. In this organism, it has been shown
that Int-6 together with eIF3-p110 interacts with the COP9
(constitutive photomorphogenesis 9)
signalosome, which plays an important role in the control of
photomorphogenesis (16). In cells of the root, Int-6 is seen
predominantly within the nucleus. In mammalian cells also, the
localization of Int-6 might differ from one cell type to another.
Recently, data on the disruption of the gene encoding the Int-6
ortholog in Schizosaccharomyces pombe have been reported by
several groups (17, 21, 22). Yeast strains lacking Int-6 were found to
grow slowly in minimal medium and to exhibit an increased sensitivity
to various drugs including caffeine, actinomycin D, and cycloheximide
(21, 22). Conversely, the overexpression of Int-6 in this organism
leads to resistance to these drugs. This effect was related to an
increase in the amounts of RNA produced by several genes regulated by
Pap-1, the S. pombe homolog of AP-1 (21). It is not yet
known whether this effect is the consequence of altered translation of
a regulatory factor or of a direct transcriptional action of Int-6. The
loss of Int-6 in S. pombe also causes a weak deleterious
effect on chromosome segregation by a modification of the microtubule
assembly/disassembly (23). This effect is highly reinforced by
mutations in the ras1 gene. A similar effect was observed
with the S. pombe homolog of eIF3-p66, Moe1, which interacts
with Int-6. Interestingly, when Moe1 is absent, the level of Int-6
decreases and its subcellular localization is modified, the
protein being then present within the nucleus. The inverse situation
occurs when the int-6 gene is disrupted. This suggests that
the interaction between Moe1 and Int-6 is important for the presence of
both proteins in the cytoplasm. The effect on chromosome segregation
might be an explanation of the transforming activity of the putative
truncated Int-6 forms resulting from mouse mammary tumor virus
integration (23). All of these data show that Int-6 exerts complex
regulatory roles in the cell and that much remains to be understood
about the function of this protein.
With the exception of Saccharomyces cerevisiae, the
conservation of Int-6 among various species of eukaryotes (S. pombe (17, 21-23), A. thaliana (16), Drosophila
melanogaster (15), Caenorhabditis elegans (19),
Xenopus laevis (19), Mus musculus (1) and Homo sapiens (2)) is high. By comparing these sequences, we noticed a good conservation of a consensus phosphorylation site on
tyrosine at position 144 in the human sequence. Experiments were
therefore undertaken to determine whether Int-6 can be phosphorylated on tyrosine. Under the conditions tested, we did not observe such a
phosphorylation, but it appeared that Int-6 coprecipitated a protein
showing an apparent molecular mass of 69 kDa, which was very clearly
revealed by anti-phosphotyrosine antibodies. This protein has been
identified by mass spectrometry, and we show in this report that it
associates with the eIF3 translation initiation factor.
 |
EXPERIMENTAL PROCEDURES |
Cell Culture and Transfection--
Jurkat and MT4 cells were
cultured in RPMI 1640 supplemented with 10% fetal calf serum at
37 °C in a 5% CO2-humidified atmosphere. BHK21 and COS7
cells were cultured under the same conditions except that the medium
was Dulbecco's modified Eagle's medium instead of RPMI. COS7 cells
were transfected by the calcium phosphate precipitation method in
100-mm diameter Petri dishes. Treatment of cells with 10 mM
H2O2 was performed by the addition of 114 µl
of a 3% H2O2 solution in 10 ml of culture
medium. After incubation for 15 min, cells were collected by
centrifugation and washed three times with phosphate-buffered saline.
The pellet of cells was stored at 80 °C after freezing in a liquid
nitrogen bath.
Immunoprecipitations and Immunoblots--
Cells corresponding to
10 ml of culture at 1 × 106 cells/ml were resuspended
in 500 µl of Nonidet P-40-desoxycholate lysis buffer (20 mM Tris, pH 7.4, 150 mM NaCl, 1% Nonidet P-40,
0.5% sodium desoxycholate) supplemented extemporaneously with 0.5 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride
hydrochloride and 40 mM sodium orthovanadate. After
20 min at 4 °C, the tubes were centrifuged at 14,000 × g for 15 min. 250 µl of the supernatant were mixed with 1 µl of antibody and incubated for 90 min at 4 °C. The mix was then
added to 25 µl of protein A beads previously equilibrated in the
Nonidet P-40-desoxycholate lysis buffer and further incubated for 60 min at 4 °C. Beads were collected by centrifugation for 2 min at
2000 rpm and washed three times with 250 µl of Nonidet
P-40-desoxycholate lysis buffer. Proteins were eluted in SDS-PAGE
loading buffer by incubation at 80 °C for 10 min. In some
experiments, the Nonidet P-40-desoxycholate lysis buffer was replaced
by the Nonidet P-40 or radioimmune precipitation buffers (24). For mass
spectrometry, immunoprecipitation was done similarly with 250 ml of
cells lysed in 10 ml of Nonidet P-40-desoxycholate lysis buffer. After
the final wash, proteins were eluted from the protein A beads (1 ml) in
2 ml of 20 mM Hepes pH 7.0, 1% SDS by incubation for 10 min at 37 °C. Proteins of the supernatant were precipitated by the
addition of four volumes of acetone (overnight at 20 °C). After
centrifugation for 30 min at 14,000 × g, the protein
pellet was dried and resuspended in SDS-PAGE loading buffer.
Proteins were separated by SDS-PAGE, transferred to polyvinylidene
difluoride (PVDF) membrane, and analyzed by immunoblot using standard
procedures. When the anti-phosphotyrosine antibodies were used, the
membrane was blocked with 5% bovine serum albumin instead of 5% dry
milk in the other cases. Revelation of the secondary antibody coupled
to peroxidase was performed using ECL or ECLplus (Amersham Pharmacia
Biotech). When probed with a secondary antibody coupled to cyanine 5, the membrane was scanned with a STORM860 apparatus (Amersham Pharmacia
Biotech).
Antibodies--
Peptides corresponding to the C-terminal 19 amino acids of HSPC021 and to the N-terminal 19 amino acids of eIF3-p66
were chemically synthesized and coupled to ovalbumin. Rabbits were
immunized with these conjugates. The antiserum was used diluted 1:1000
for immunoblotting and 1:250 for immunoprecipitation.
Mass Spectrometry--
Proteins were separated by SDS-PAGE and
stained with a zinc stain kit (Bio-Rad), and the band at 69 kDa was
excised. After a wash with 50% acetonitrile, gel pieces were dried in
a vacuum centrifuge and reswollen in 20 µl of 25 mM
NH4HCO3 containing 0.5 µg of sequencing grade
trypsin (Promega). After incubation for 4 h at 37 °C, a
0.5-µl aliquot was removed for matrix-assisted laser
desorption/ionization time-of-flight mass spectrometry (MALDI-TOF/MS) analysis. Monoisotopic peptide masses were assigned and used for data
base searching. The gel pieces were then extracted with 5% formic acid
solution and then with acetonitrile. The extracts were combined with
the original digest, and the sample was evaporated to dryness. The
sample was dissolved in 0.1% formic acid and desalted using a Zip Tip
(Millipore Corp.). Elution of the peptides was performed with 5-10
µl of 50% acetonitrile, 0.1% formic acid solution. The peptide
solution was introduced into a glass capillary (Protana) for
nanoelectrospray ionization. Tandem mass spectrometry experiments were
carried out on a Q-TOF hybrid mass spectrometer (Micromass) in order to
obtain sequence information.
Gel Filtration Column--
100 × 106 Jurkat
cells were lysed by freeze-thaw in 400 µl of buffer A (50 mM Hepes, pH 8.0, 300 mM NaCl, 5 mM
MgCl2, 1 mM dithiothreitol, 10% glycerol,
protease inhibitor mixture (complete EDTA free (Roche Molecular
Biochemicals)). Lysate was cleared by centrifugation and subjected to
nuclease digestion for 90 min (benzonase; Sigma). The whole cell
extract was loaded at a flow rate of 0.3 ml/min on a Superose 6 HR10/30
gel filtration column (Amersham Pharmacia Biotech) equilibrated with 20 mM Tris-HCl, pH 7.4, 300 mM NaCl, 10% (v/v)
glycerol, 1 mM dithiothreitol. Fractions of 0.6 ml each
were collected and concentrated with 25 µl of StrataClean resin
(Stratagene). Gels for immunoblots were done with one-fifth of each fraction.
Constructs--
The HSPC021 cDNA was obtained from the
United Kingdom Human Genome Mapping Project Resource Center (Image
clone 2518785) (25). The HSPC021 coding sequence was amplified by PCR
with the following sense and antisense primers:
5'-CGCAAGATCTACATATGTCTTATCCCGCTGATG-3' and
5'-TGTGTAGATCTCATCAAGGTCTCTGTCCCATC-3', respectively. After digestion
by BglII, the fragment was cloned into the BglII
site of the pSG5 (26) derivative pTL1, giving pTL1-HSPC021. The
pSGF-HSPC021 plasmid contains the HSPC021 cDNA fused at its 5'-end
to the FLAG epitope into pSG5. It was generated by amplifying the
HSPC021 coding sequence from the pTL1-HSPC021 plasmid with the
following sense primer: 5'-CAGCCAGATCTTATCCCGCTGATGATTATG-3', along
with the antisense primer indicated above. After digestion by
BglII, the fragment was inserted into the BamHI
restriction site of pSGFLAG (2). The N-terminal HSPC021 deletion
mutants, pSGF-306/564 and pSGF-358/564, as well as the C-terminal
deletion mutants, pSGF-1/466 and pSGF-1/536, were constructed by
inserting into the BamHI site of pSGFLAG the corresponding
cDNA fragments obtained by PCR amplification using pSGF-HSPC021 as
matrix along with appropriate primers, which created BglII
sites at both ends. The pTL1-Int-6 plasmid has been described
previously (19). The vector used to express Int-6 in bacteria was
generated by amplifying the Int-6 cDNA from pTL1-Int6 with
Pfu polymerase and primers sharing a stretch of 20 nucleotides homologous to pET-15b at both ends. The sequence of the
sense and antisense primers was as follows: 5'-GGCCTGGTGCCGCGCGGCAGCGCGGAGTACGACTTGACTAC-3' and
5'-CTCAGCTTCCTTTCGGGCTTCTTCAGTAGAAGCCAGAATC-3'. The PCR product
was cloned by homologous recombination (27) in pET-15b vector (Novagen)
digested with NdeI and BamHI. For the HSPC021
bacterial expression vector, the cDNA was amplified by PCR as for
pSGF-HSPC021 and inserted into the BglII site of the
bacterial expression vector pFLAG-2 (Sigma).
Production of Recombinant Proteins and Far Western
Blots--
Wild-type HSPC021 and a FLAG-tagged form were synthesized
by in vitro transcription/translation using the
TranscendTM tRNA and the TNT Coupled Reticulocyte Lysate
systems (Promega). 1 µg of plasmids pTL1-HSPC021 and pSGF-HSPC021
were added to reaction mixtures of 50 µl, and assays were carried out
according to the manufacturer's protocol. To verify the incorporation
of biotinylated lysine residues into newly synthesized proteins, 2-µl
aliquots were loaded on an SDS-polyacrylamide gel, transferred to PVDF, and analyzed with streptavidin coupled to peroxidase. The remaining 48 µl of reaction mixtures were diluted in Nonidet P-40 buffer and used
for immunoprecipitation experiments.
FLAG-tagged HSPC021 was also produced in bacteria. E. coli
BL21 transformed with the pFLAG-2-HSPC021 plasmid were grown in LB
medium at 37 °C to midexponential phase. Induction was carried out
at 37 °C with 1 mM
isopropyl-1-thio- -D-galactopyranoside for 3 h.
Cells were centrifuged at 4000 × g; resuspended in 100 mM Tris-HCl, pH 7.5, 200 mM NaCl, 10 mM MgCl2, 1000 units of benzonase, 0.5 mg/ml
lysozyme, Complete EDTA-free inhibitor mixture (Roche); and sonicated
three times for 1 min at 30 watts. Suspension was clarified by
centrifugation at 10,000 × g for 30 min and applied on
a FLAG-M2-agarose affinity column (Sigma) equilibrated in TBS (50 mM Tris-HCl, pH 7.4, 150 mM NaCl). Recombinant
protein was eluted with 100 µg/ml FLAG peptide in TBS.
To produce Int-6 in bacteria, the E. coli BL21 strain was
transformed with the pET-15b-Int-6 plasmid. Bacteria were grown in LB
medium at 37 °C to midexponential phase and were induced at 28 °C
with 1 mM
isopropyl-1-thio- -D-galactopyranoside for 16 h.
Cells were centrifuged at 4000 × g; resuspended in 50 mM NaH2PO4, pH 8.5, 300 mM NaCl, 2% LDAO, 10 mM imidazole, 1000 units of benzonase, 0.5 mg/ml lysozyme, Complete EDTA-free inhibitor mixture (Roche Molecular Biochemicals); and sonicated three times for 1 min at 30 watts. Suspension was centrifuged at 10,000 × g for 30 min and applied onto a nickel-nitrilotriacetic
acid-agarose (Qiagen) chromatography column equilibrated with 50 mM NaH2PO4, pH 8.5, 300 mM NaCl, 0.5% LDAO and connected to a Beckman high pressure liquid chromatography system. Elution was performed with a
linear gradient to 0.5 M imidazole in 50 mM
NaH2PO4, pH 8.5, 300 mM NaCl, 0.5%
LDAO. The His-tagged Int-6 fractions, eluted between 150 and 200 mM imidazole, were pooled and concentrated on Centricon 30 (Millipore Corp.). Full-length Int-6 and a C-terminal truncated form
were separated on a Superdex 200 HiLoad 16/60 gel filtration column
(Amersham Pharmacia Biotech) equilibrated with 50 mM
NaH2PO4, pH 8.5, 300 mM NaCl, 0.5%
LDAO, 1 mM dithiothreitol, 1 mM EDTA at a flow
rate of 1 ml/min. Amino acid analysis of the truncated form showed that
it corresponds to the N-terminal 211 amino acids of Int-6.
For Far Western blots, 250 and 500 ng of FLAG-tagged HSPC021 expressed
in E. coli and purified as described above were loaded onto
a SDS-polyacrylamide gel and blotted to PVDF. Membranes were blocked
overnight at 4 °C with 5% dry milk in phosphate-buffered saline and
then incubated for 2 h at room temperature with either the
full-length recombinant Int-6 or the C-terminal truncated form. Both
proteins were used at a concentration of 1.5 µg/ml in 0.5% LDAO in
phosphate-buffered saline. Membranes were washed three times in
phosphate-buffered saline with 0.1% Tween and incubated with the
antibody directed against the N-terminal 19 residues of Int-6 (19).
 |
RESULTS AND DISCUSSION |
Coprecipitation of Int-6 with a Phosphotyrosine Protein--
It is
known that treatment of cells with phosphatase inhibitors like
H2O2 or pervanadate causes a rapid and strong
induction of protein phosphorylation on tyrosine. This phenomenon is
reversible and has been observed with membrane fractions of Jurkat cell
extracts (28). This induction of phosphorylation, which resembles that resulting from TCR/CD3 stimulation, was not observed in the Jurkat variant JCAM, which is deficient in the Lck tyrosine kinase (28). To
seek for phosphorylation on tyrosine of Int-6 in T cells, we prepared
extracts from either normal or H2O2-treated
Jurkat cells. This was also done with the MT4 T-cell line. Immunoblot
analysis of these extracts with antibodies recognizing phosphotyrosine proteins showed that H2O2 indeed induced
appearance of multiple bands in both cell lines (Fig.
1, compare lanes 2 and 4 with lanes 1 and 3,
respectively). These extracts were used for immunoprecipitation experiments with an antibody directed against the C-terminal 20 amino
acids of Int-6 (19). Immunoblot analysis with the antibody to
phosphotyrosine of the precipitated proteins did not reveal any band at
the position of Int-6. Analysis of the same membrane using an antibody
directed against the C-terminal 169 amino acids of Int-6 (19), together
with a secondary antibody fluorescently labeled with cyanine 5, showed
that equal amounts of Int-6 were precipitated with extracts of both
untreated and H2O2-treated cells (Fig.
1C). These data indicate that, under these conditions, either Int-6 is not phosphorylated on tyrosine or such a modification was not recognized by the antibodies to phosphotyrosine that were used.
By contrast, the same immunoblot showed a clear band at an apparent
molecular mass of 69 kDa (Fig. 1B). This band was observed
with extracts of both Jurkat and MT4
H2O2-treated cells (Fig. 1B,
lanes 2 and 5). It was not observed
with extracts of untreated cells or when the antibody to Int-6 was
omitted in the immunoprecipitation reaction (Fig. 1B,
lanes 1, 3, 4, and
6). With the extract of H2O2-treated
Jurkat cells, a band was also seen at 55 kDa (Fig. 1B,
lane 2). At this position, a nonspecific band due
to cross-reaction with protein A released from the beads was observed
(Fig. 1B, lanes 3 and 6).
It is not clear why this nonspecific band was reinforced by the
H2O2 treatment with the Jurkat cell extract,
but it was not further considered. These observations showed that Int-6
is apparently not phosphorylated on tyrosine by itself but is
associated with a phosphotyrosine protein of 69 kDa.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 1.
Association of Int-6 with a p69
phosphotyrosine protein. A, Jurkat and MT4 cells were
untreated (lanes 1 and 3) or treated
with 10 mM H2O2 (lanes
2 and 4) and lysed in Nonidet P-40-desoxycholate
buffer. Cell extracts were analyzed by immunoblot with a mix of two
monoclonal antibodies directed against phosphotyrosine: 4G10 (ascites
supernatant diluted 1:40) and pY99 (purified antibody diluted 1:1000;
Santa Cruz Biotechnology, Inc., Santa Cruz, CA). B,
immunoprecipitation using the C-20 antibody to Int-6 was performed with
extracts of untreated (lanes 1 and 4)
or H2O2-treated (lanes 2 and 5) Jurkat (lanes 1 and
2) and MT4 (lanes 4 and 5)
cells. In lanes 3 and 6, the
experiment was performed as in lanes 2 and
5 except that the antibody was omitted as a control. The
positions of the bands of a molecular weight marker run in parallel are
given together with that of the p69 band. n.s., a
nonspecific signal due to cross-reaction with the immunoglobulin heavy
chain, as well as with protein A released from the beads. C,
the same membrane as in B was analyzed with the C-169
antibody to Int-6 and a fluorescently labeled secondary antibody. The
image obtained by scanning the membrane using the STORM 860 apparatus
is shown. The position of the signal corresponding to Int-6 is
indicated.
|
|
Identification of p69 by Mass Spectrometry--
To characterize
p69, immunoprecipitation using the C-20 antibody to Int-6 was performed
on a larger scale (see "Experimental Procedures"). Proteins were
eluted by incubation in a buffer containing 1% SDS at 37 °C. This
moderate temperature was important to avoid release of contaminant
proteins associated with the beads (data not shown). After acetone
precipitation and SDS-PAGE, the gel was stained, and the band migrating
at 69 kDa was excised. Proteins present in the gel piece were digested
with trypsin, and peptides were analyzed by mass spectrometry.
MALDI-TOF analysis indicated that 12 of 25 peptides matched with a
GenBankTM entry named HSPC021 (accession number AF077207)
(Fig. 2A). In order to verify
the presence of HSPC021 within this band, which was very likely to
contain a protein mixture, tandem mass spectrometry experiments were
carried out. MS/MS results confirmed that HSPC021 was the main protein
within this gel piece (Fig. 2A). This analysis also revealed
the presence in lesser amounts of eIF3-p66 (data not shown). The same
approach was taken using a band migrating at ~175 kDa, and we
identified it as eIF3-p170 (data not shown).

View larger version (50K):
[in this window]
[in a new window]
|
Fig. 2.
A, sequence of the peptides of HSPC021
identified by MALDI-TOF or MS/MS. The sequence of HSPC021 is shown.
Residues in boldface type correspond to peptides
identified by MS/MS. Residues underlined correspond to
peptides identified by MALDI-TOF. 12 of 25 peptides characterized by
MALDI-TOF corresponded to HSPC021. B, protein domains of the
rice, nematode, fly, and human HSPC021. The sequences of HSPC021 from
Oryza sativa (Os), C. elegans
(Ce), D. melanogaster (Dm), and
H. sapiens (Hs) were analyzed by the pfscan
program on the ISREC Profile Scan Server. The PCI domain
(light gray box), the
tetratricopeptide repeat (TPR) (gray
box), and the Pumilio FBF RNA binding domain repeat
(Puf R) (black box) are represented.
The PCI domains are located between positions 407 and 484 in C. elegans and between positions 403 and 465 in O. sativa.
The tetratricopeptides are between positions 313 and 346 in H. sapiens and between positions 284 and 317 in D. melanogaster. The Puf repeat is between positions 512 and 537 in
D. melanogaster. The GenBankTM accession numbers
for these sequences are as follows: H. sapiens, AF077207;
D. melanogaster, AE003542; C. elegans, U28739;
O. sativa AP001859 (BAA94770).
|
|
Data bank searches showed that HSPC021 is well conserved among distant
organisms. Homologs are indeed present in rice, Drosophila, and nematode. However, this search did not identify homologs in both
S. pombe and S. cerevisiae. The sequence of the
different HSPC021s was scanned using the pfscan program on the ISREC
server (available on the World Wide Web at
www.isrec.isb-sib.ch/software/) to identify particular protein domains.
This showed that the rice and nematode proteins contain a
proteasome-COP9 signalosome-initiation factor 3 (PCI) domain (29) (Fig.
2B). The program did not identify it in the human and
Drosophila sequences, but the region is well conserved
(36.4% identity and 39.0% similarity between C. elegans and H. sapiens; 40.3% identity and 37.7% similarity
between C. elegans and D. melanogaster). This
motif exists in three subunits of eIF3 (p170, p110, and Int-6), in five
subunits of the lid of the human 26 S proteasome (PSMD-3, -12, -6, -8, and -13), and in six subunits of the human COP9 signalosome (CSN1, -2, -3, -4, -7, and -8). Scanning of the Drosophila and human
proteins identified a tetratricopeptide repeat (Fig. 2B).
This motif, present in one or several copies in various proteins, folds
into two antiparallel -helices and is involved in protein-protein
interactions (30). Association of at least three repeats forms a domain
to which peptides can bind in an extended conformation (31). Finally, this analysis showed that the Drosophila sequence contains a
Pumilio-FBF repeat (Puf repeat). This sequence is present in the RNA
binding domain of the Drosophila protein Pumilio that
regulates translation of the hunchback mRNA. A complex between the
mRNA, Pumilio, Nanos, and brain tumor impedes its translation in
the posterior compartment of the Drosophila embryo (32-35).
The Pumilio RNA binding domain includes eight Puf repeats plus
additional sequences at the N-terminal and C-terminal boundaries (36).
The recent determination of the structure of the Puf domain showed that
the Puf repeats fold into a motif including three -helices, which
form a rainbow-like arc (37). Interestingly, this structure can be
compared with that formed by armadillo repeats of -catenin, the HEAT
repeats of protein phosphatase 2A, and the tetratricopeptide repeats of protein phosphatase 5 (37). All of these proteins can be considered as
members of a family of helical repeat proteins that present a surface
for interaction with other molecules, proteins or RNAs. A Puf repeat
was not detected by the program in human HSPC021, but this part is very
well conserved between Drosophila and humans (64% identity
and 36% similarity). This motif is also well conserved between
Drosophila and nematode (32% identity and 56% similarity). It is intriguing that Drosophila HSPC021 includes both a
tetratricopeptide and Puf repeat. Considering the similarity between
the structures of these motifs, it is possible that they participate to
a larger conformation interacting with other proteins. In this regard, it is interesting to note that a Puf repeat also exists in the CSN2
subunit of the human COP9 signalosome and that the CSN1 and CSN3
subunits of this complex include a tetratricopeptide repeat.
To confirm that p69 indeed corresponded to HSPC021, a rabbit polyclonal
antibody directed against the C-terminal 19 amino acids of the protein
was generated. As tested with extracts of Jurkat cells, this antibody
revealed a unique band at 69 kDa, in agreement with the calculated
molecular mass of 66.7 kDa (data not shown and Fig.
3, B and C,
lanes 1). Extracts of Jurkat cells treated with
H2O2 were immunoprecipitated with antibodies to
either Int-6 or HSPC021. Proteins were analyzed by immunoblot with
antibodies directed against either HSPC021 or phosphotyrosine. This
experiment showed that HSPC021 was precipitated with equal efficiencies
by antibodies to Int-6 or to HSPC021 (Fig. 3A,
lanes 2 and 3). This suggests that all
HSPC021 is bound to Int-6. This also showed that the band recognized by
the antibody to HSPC021 is the same as that revealed by the antibody to
phosphotyrosine. These results establish that the phosphotyrosine
protein precipitated with Int-6 is HSPC021. It was further examined
whether the association of Int-6 with HSPC021 depends on the
H2O2 treatment (i.e. on the phosphorylation on tyrosine of HSPC021). To this end, proteins from
Jurkat cells either untreated or H2O2-treated
were immunoprecipitated using the antibody to Int-6 and analyzed by
immunoblot with the antibody to HSPC021. The association of HSPC021
with Int-6 was not significantly modified by exposure of the cells to
H2O2 (Fig. 3B, compare
lanes 4 and 6). Direct analysis of the
extracts did not show any variation in the amount of HSPC021 in
response to the H2O2 treatment (Fig.
3B, lanes 1 and 2). It was
further evaluated whether the association of Int-6 with HSPC021 also
occurs in cell types other than T-cells. Extracts of BHK21 and COS7
cells were immunoprecipitated using the C-20 antibody to Int-6 and
analyzed by immunoblotting with the antibody to HSPC021. This latter
protein was found to be present in the immunoprecipitated proteins in both cell types (Fig. 3C, lane 3).
Taken together, these data show that HSPC021 is associated with Int-6
in various cell types and that phosphorylation of HSPC021 on tyrosine
does not impede or increase this interaction.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 3.
The p69 phosphotyrosine protein is
HSPC021. A, extracts of
H2O2-treated Jurkat cells were used for
immunoprecipitation using the antibody directed against the C-terminal
20 amino acids of either Int-6 (lane 2) or
HSPC021 (lane 3). Proteins were analyzed by
immunoblot with the antibody to HSPC021 (upper
panel) as well as antibodies to phosphotyrosine as described
in the legend to Fig. 1 (lower panel). As a
control, antibody was omitted in the immunoprecipitation reaction
(lane 1). The position of the 75-kDa band of a
molecular weight marker run in parallel is indicated. B,
extracts of untreated or H2O2-treated Jurkat
cells were directly analyzed using the antibody to HSPC021 or used for
immunoprecipitation with the antibody to Int-6. In lanes
3 and 5, the antibody was omitted in the
immunoprecipitation reaction. C, extracts of BHK21
(upper panel) as well as of COS7 cells
(lower panel) were directly analyzed by
immunoblot using the antibody to HSPC021 (lane 1)
or used for immunoprecipitation with the antibody to Int-6
(lane 3). In lane 2, the
antibody was omitted.
|
|
HSPC021 Is Associated with Human eIF3--
As discussed
previously, Int-6 is present in multiple protein complexes. In order to
evaluate whether HSPC021 is also part of a larger protein assembly, a
Jurkat whole cell extract was fractionated on a gel filtration column.
Each fraction was tested by immunoblot for the presence of Int-6,
HSPC021 and eIF3. The eIF3 antibody, a kind gift of Dr. Hershey, does
not recognize with equal efficiency all of the subunits of the complex
(3). Under these conditions, mainly four of them were detected: p170; p116 and p110, which both appeared as a single band; and p44. By
considering these bands, eIF3 was observed to elute in five fractions
(Fig. 4, lanes
6-10) with an apparent molecular mass of 900 kDa, which is
significantly larger than that previously given for purified eIF3
(~600 kDa). Int-6 was clearly observed in the five fractions where
the four other subunits of eIF3 were present, but it was also present
in fractions corresponding to lower molecular weights in which p170 and
p44 were absent. HSPC021 exhibited a pattern very similar to that of
Int-6 although slightly less extended toward the lower molecular
weights (Fig. 4, lane 12). These data suggested
that HSPC021 might be associated with eIF3, although previous
systematic analyses did not identify this protein in purified forms of
the translation initiation factor. Several experiments were undertaken
to test this hypothesis. The antibody directed against eIF3 was used to
perform immunoprecipitations using extracts of Jurkat cells. To
evaluate whether the association of HSPC021 with eIF3 is weak, this
being a possible explanation for the absence of HSPC021 in purified
eIF3s, the extracts were prepared in two types of buffer: the Nonidet
P-40 lysis buffer and the more stringent radioimmune precipitation
buffer. Proteins immunoprecipitated by the antibody to eIF3 were
analyzed by immunoblot using the anti-HSPC021 antibody. A strong signal
at 69 kDa was observed with both buffers (Fig.
5A, lanes
4 and 6). Immunoblot analysis of purified
bacterially expressed HSPC021 indicated that the eIF3 antibody was not
able to recognize the band corresponding to this protein (data not
shown). Thus, the precipitation of HSPC021 by the eIF3 antibody is
probably due to a tight association between the protein and the complex
rather than to a direct binding of the immunoglobulins to HSPC021. The
inverse experiment was performed but gave negative results. The exact
reason for this is not known, but the most likely explanation is that
the binding of the immunoglobulins to HSPC021 hinders association of
the protein with eIF3. We then asked whether phosphorylated HSPC021
also binds to eIF3. Proteins of an extract of Jurkat cells exposed to
H2O2 were precipitated with the antibody to
eIF3 and analyzed by immunoblot with the antibodies directed against
phosphotyrosine. This experiment clearly detected the band at 69 kDa
(Fig. 5B, lane 2). This band was not very intense, but the efficiency of the induction of phosphorylation on
tyrosine was not very high in this particular extract (data not shown).
We conclude from this result that phosphorylation of HSPC021 on
tyrosine does not impede its association with eIF3.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 4.
Coelution of eIF3, HSPC021, and Int-6 on a
gel filtration column. A whole cell extract of Jurkat cells was
loaded on a Superose 6 gel filtration column. Fractions were analyzed
by immunoblot with antibodies to eIF3 (upper
panel), HSPC021 (middle panel), and
Int-6 (lower panel). Lane 1 corresponds to the extract loaded onto the column. The elution volume
corresponding to the different fractions in ml is indicated at the
top. The column was calibrated with protein standards. Their
position of elution is indicated above the immunoblots.
|
|

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 5.
Association of HSPC021 with eIF3.
A, Jurkat cell extracts were prepared in either Nonidet P-40
(lane 1) or radioimmune precipitation
(lane 2) buffers. These extracts were used for
immunoprecipitation using the antibody directed against eIF3
(lanes 4 and 6), and precipitated
proteins were analyzed by immunoblot with the antibody to HSPC021. In
lanes 3 and 5, normal goat serum was
used in the immunoprecipitation reaction as a control. The positions of
the 83- and 62-kDa bands of molecular mass markers are represented.
B, an extract of H2O2-treated Jurkat
cells was used for immunoprecipitation using the antibody to eIF3, and
immunoblotting was done with the antibodies directed against
phosphotyrosine. In lane 1, the antibody was
omitted. C, an extract of Jurkat cells was used for
immunoprecipitation using the antibody to eIF3-p66. Immunoblotting was
done with the antibodies directed against either p66 (lanes
1-3) or HSPC021 (lanes 4-6). In
lanes 1 and 4, the extract was
directly loaded. In lanes 2 and 5, the
antiserum was replaced by preimmune serum as control. The position of
the signal corresponding to either p66 or HSPC021 (p69) is indicated.
D, constructs expressing HSPC021 either with an N-terminal
FLAG tag (lanes 1 and 2) or without
(lanes 3 and 4) were used for in
vitro transcription/translation using the TNT system (Promega).
Proteins were labeled by the addition in the reaction of biotinylated
lysines. The products were diluted in Nonidet P-40 buffer, and
immunoprecipitations were carried out using the antibody to eIF3. After
SDS-PAGE and transfer to PVDF, the membrane was probed with
streptavidin coupled to peroxidase. In lanes 1 and 3, normal goat serum was used in the immunoprecipitation
reaction.
|
|
The antibody directed against the C-terminal 20 amino acids of Int-6
reacts only against this specific subunit of eIF3 and precipitates
HSPC021 (Fig. 3). To further strengthen the notion that HSPC021 is
associated with eIF3 and to establish that its precipitation by the
eIF3 antibody was not due to a poor specificity of this goat antiserum,
it was also tested whether an antibody raised against the N-terminal 19 amino acids of eIF3-p66 precipitates HSPC021. Immunoblot analysis of an
extract of Jurkat cells with this antibody revealed a unique band at
the correct molecular weight (Fig. 5C, lane
1). It was verified whether this antibody also worked for
immunoprecipitation by analyzing the precipitated proteins by
immunoblot with the same antibody. With the exception of the strong
nonspecific signal due to the heavy chain of the immunoglobulins, this
revealed a unique band at the position of p66 (Fig. 5C,
lane 3). However, the intensity of the signal
observed was not very strong, indicating that the ability of this
antibody to work for immunoprecipitation was limited. The same
experiment was done except that the antibody to HSPC021 was used to
analyze the precipitated proteins by immunoblot. The band corresponding to HSPC021 was clearly detected (Fig. 5C, lane
6), and replacement of the antibody to eIF3-p66 by the
preimmune serum in the immunoprecipitation led to a negative result
(Fig. 5C, lane 5). This showed that in addition
to that directed against Int-6, another antibody specific for a single
subunit of eIF3 was able to precipitate HSPC021.
To further strengthen the notion that this protein is associated with
the translation initiation factor, it was tested whether newly
synthesized HSPC021 could incorporate into eIF3. Both wild type and a
N-terminal FLAG-tagged form of HSPC021 were produced by in
vitro coupled transcription/translation. During synthesis, proteins were labeled by incorporation of biotinylated lysines. Proteins were immunoprecipitated using the antibody to eIF3 and analyzed by immunoblot with streptavidin coupled to peroxidase. For
both proteins, the signal at 69 kDa was clearly detected (Fig. 5D, lanes 2 and 4).
Similar experiments were also performed by transfecting COS7 cells with
vectors expressing FLAG-tagged forms of HSPC021 corresponding to either
the entire coding sequence or both N-terminal and C-terminal deletion
mutants (Fig. 6A). All
proteins were expressed at the same level (Fig. 6B).
Extracts of transfected cells were precipitated with the antibody to
eIF3, and immunoblot was performed with the M2 monoclonal antibody
directed against the FLAG epitope. A band at 69 kDa was clearly
observed in the extracts corresponding to expression of the entire
HSPC021 protein (Fig. 6C, lanes 2 and 6), but for each mutant no signal was observed (Fig.
6C, lanes 3, 4,
7, and 8). This experiment showed that HSPC021
incorporates into endogenous eIF3 and that this event is hindered by
alterations of both N-terminal and C-terminal ends of the protein.
Either loss of important domains or alteration of the overall structure of the protein might explain this lack of incorporation into eIF3. That
the putative Puf repeat at the end of the protein is necessary (mutant
1-536) is likely to explain why binding of the antibody directed
against the last 19 amino acids of HSPC021 impedes its association with
eIF3 (see above).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Incorporation of transiently expressed
HSPC021 into endogenous eIF3. A, plasmids expressing
HSPC021 complete or including different N-terminal or C-terminal
deletions, in fusion with the FLAG epitope at the N-terminal end were
constructed. The proteins produced by these plasmids are schematized.
The tetratricopeptide repeat of human HSPC021 as well as the PCI domain
and Puf repeat present in HSPC021 of other species are represented.
B, COS7 cells were transfected with these vectors and
extracts of these cells were analyzed by immunoblot using the M2
monoclonal antibody directed against FLAG. The positions of the bands
of a molecular weight marker run in parallel are given. C,
these extracts were used for immunoprecipitation with the antibody
directed against eIF3. In lanes 1 and
5, normal goat serum was used in the immunoprecipitation
reaction as a control. Precipitated proteins were analyzed by
immunoblot with the antibody to FLAG. The position of the entire
FLAG-tagged HSPC021 is indicated (FH).
|
|
Taken together, these results establish that HSPC021 specifically binds
eIF3. Previous works with purified eIF3 did not identify this protein.
The exact reason for this discrepancy is not known. A survey of the
numerous expressed sequence tags corresponding to HSPC021 indicates
that it is ubiquitously expressed; hence, the reason for its absence in
purified eIF3 is probably not the consequence of a lack of expression.
The most likely explanation is that the purification processes caused
removal of this subunit. In agreement with this possibility is the fact
that the size of the complex observed in the gel filtration column
appears higher than that reported for purified eIF3. A strong support
to the notion of HSPC021 being tightly associated with eIF3 comes also from results published during completion of this work on the A. thaliana eIF3. Indeed, it has been reported that eIF3 purified from this organism includes 12 subunits, one of them corresponding to
the A. thaliana homolog of HSPC021 (38). In agreement with the data published by Burks et al., the results presented in
this paper show that HSPC021 strongly binds the eIF3 translation
initiation factor in mammals. The data previously obtained
in vitro with the purified form of eIF3 indicate that
HSPC021 is not essential to the activity of this translation factor.
This protein is likely to have a regulatory role, which remains
to be understood.
Protein-Protein Interaction of HSPC021 with Int-6--
Assuming
that HSPC021 binds eIF3, we wondered whether its association with Int-6
was direct or depended on other proteins of the translation initiation
factor. This was first evaluated by coexpressing Int-6 with the various
FLAG-tagged forms of HSPC021 in COS7 cells. Int-6 was found to
coprecipitate with the entire HSPC021 but also with the four mutants
(Fig. 7A). This was clearly dependent upon expression of the different HSPC021 forms, since no
signal at the position of Int-6 was detected when cells were transfected only with the Int-6 expression vector (Fig. 7A,
lanes 1 and 5). Since the HSPC021
mutants did not incorporate into eIF3 (Fig. 6C), this result
is in favor of a direct protein-protein interaction between HSPC021 and
Int-6. To further establish this point, Far Western experiments were
performed with bacterially expressed proteins. FLAG-tagged HSPC021 was
produced in E. coli and purified by affinity onto an
anti-FLAG M2 gel. The purified FLAG-HSPC021 protein was migrated
through a SDS protein gel and transferred to PVDF membranes. These
latter were incubated with two forms of Int-6 coupled to a
polyhistidine motif, which were produced in E. coli and
purified onto nickel-agarose followed by a gel filtration column. The
presence of both proteins on the membranes was detected by immunoblot
using the antibody directed against the N-terminal 19 amino acids of
Int-6. Both proteins bound to HSPC021 (Fig. 7B,
lanes 2, 3, 5, and
6) but not to bovine serum albumin, which was used as a
control (Fig. 7B, lanes 1 and 4). The efficiency of the binding was higher with the
N-terminal fragment of Int-6 corresponding to the first 211 amino
acids, but this was probably related to the propensity of the entire Int-6 to aggregate.

View larger version (52K):
[in this window]
[in a new window]
|
Fig. 7.
Direct protein-protein interaction between
HSPC021 and Int-6. COS7 cells were transfected with vectors
expressing Int-6 (all lanes) and the FLAG-tagged
HSPC021, either complete (lanes 2 and
6) or with the different N-terminal and C-terminal deletions
as indicated (lanes 3, 4,
7, and 8). Immunoprecipitation was performed with
the antibody to FLAG and immunoblot with the antibody to Int-6. The
position of the signal corresponding to Int-6 is indicated.
B, bovine serum albumin (lanes 1 and
4) and bacterially expressed HSPC021 (lanes
2, 3, 5, and 6) migrated
through a 10% polyacrylamide SDS gel were transferred to PVDF. The
membranes were incubated with purified entire or C terminus-truncated
Int-6. These proteins were further detected by probing with an antibody
directed against the N-terminal 19 amino acids of Int-6. The amount of
bovine serum albumin or HSPC021 used in the gel is indicated in ng. The
position of the band corresponding to the entire FLAG-tagged HSPC021 is
indicated (FH), together with that of the bands of a
molecular weight marker run in parallel.
|
|
These data show that a direct protein-protein interaction exists
between Int-6 and HSPC021 and that this interaction involves the
N-terminal moiety of Int-6. In HSPC021, the only domain common to both
358/564 and 1/466 mutant is the PCI domain (Fig. 6A), suggesting that this part is likely to play an important role in the
interaction. Therefore, a direct interaction between Int-6 and HSPC021
exists, but it is not sufficient to allow association of HSPC021 with
eIF3, since mutants that efficiently bind to Int-6 were not detected
into the translation initiation factor. This event is likely to require
binding of HSPC021 to other subunits of eIF3.
In conclusion, the data presented in this report show that HSPC021 is a
eIF3-associated protein that can be phosphorylated on tyrosine and that
directly interacts with Int-6. Interestingly, eIF3-p170 has been shown
recently to bind to the intracellular domain of the receptor tyrosine
kinase TrkA (39). This suggests that the activity of eIF3 might be
modulated by tyrosine kinases. Future studies should help to understand
how post-translational modifications of the eIF3 subunits affect
translation. In particular, it will be important to determine whether
these events affect this process globally or allow modulation of
translation of specific mRNAs. The complexity of eIF3 suggests that
it can integrate many regulatory events. This might be a feature shared
by the COP9 signalosome and by the lid of the 26 S proteasome, which
exhibit similar organizations. Deciphering the various pathways that
modulate the activity of these complexes involved in translation
initiation, transcriptional regulation, and protein degradation
represents an exciting challenge.
 |
ACKNOWLEDGEMENTS |
We thank J. W. Hershey for the generous
gift of the antibody directed against eIF3. We are indebted to A. Roisin for help with cell culture and to J. Maryanski for critical
reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported by the "Équipes
Labelisées" program of the Ligue Nationale Contre le Cancer.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
These authors contributed equally to this work.
To whom correspondence should be addressed. Tel.:
33-4-7272-8563; Fax: 33-4-7272-8080; E-mail:
pjalinot@ems_lyon.fr.
Published, JBC Papers in Press, October 4, 2001, DOI 10.1074/jbc.M104966200
 |
ABBREVIATIONS |
The abbreviations used are:
eIF, eukaryotic translation initiation factor;
CSN, COP9 signalosome;
MALDI-TOF, matrix-assisted laser desorption/ionization time-of-flight;
MS, mass spectrometry;
PAGE, polyacrylamide gel electrophoresis;
PCI, proteasome-COP9 signalosome-initiation factor 3;
PCR, polymerase chain
reaction;
Puf, Pumilio FBF;
PVDF, polyvinylidene difluoride;
LDAO, N,N-dimethyldodecylamine N-oxide;
I.P., immunoprecipitation;
I.B., immunoblot.
 |
REFERENCES |
| 1.
|
Marchetti, A.,
Buttitta, F.,
Miyazaki, S.,
Gallahan, D.,
Smith, G. H.,
and Callahan, R.
(1995)
J. Virol.
69,
1932-1938[Abstract]
|
| 2.
|
Desbois, C.,
Rousset, R.,
Bantignies, F.,
and Jalinot, P.
(1996)
Science
273,
951-953[Abstract]
|
| 3.
|
Asano, K.,
Merrick, W. C.,
and Hershey, J. W.
(1997)
J. Biol. Chem.
272,
23477-23480[Abstract/Free Full Text]
|
| 4.
|
Johnson, K. R.,
Merrick, W. C.,
Zoll, W. L.,
and Zhu, Y.
(1997)
J. Biol. Chem.
272,
7106-7113[Abstract/Free Full Text]
|
| 5.
|
Methot, N.,
Rom, E.,
Olsen, H.,
and Sonenberg, N.
(1997)
J. Biol. Chem.
272,
1110-1116[Abstract/Free Full Text]
|
| 6.
|
Asano, K.,
Vornlocher, H. P.,
Richter-Cook, N. J.,
Merrick, W. C.,
Hinnebusch, A. G.,
and Hershey, J. W.
(1997)
J. Biol. Chem.
272,
27042-27052[Abstract/Free Full Text]
|
| 7.
|
Asano, K.,
Kinzy, T. G.,
Merrick, W. C.,
and Hershey, J. W.
(1997)
J. Biol. Chem.
272,
1101-1109[Abstract/Free Full Text]
|
| 8.
|
Bandyopadhyay, A.,
and Maitra, U.
(1999)
Nucleic Acids Res.
27,
1331-1337[Abstract/Free Full Text]
|
| 9.
|
Block, K. L.,
Vornlocher, H. P.,
and Hershey, J. W.
(1998)
J. Biol. Chem.
273,
31901-31908[Abstract/Free Full Text]
|
| 10.
|
Merrick, W. C.,
and Hershey, J. W. B.
(1996)
in
Translational Control
(Hershey, J. B. W.
, Mathews, M. B.
, and Sonenberg, N., eds)
, pp. 31-70, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 11.
|
Phan, L.,
Zhang, X.,
Asano, K.,
Anderson, J.,
Vornlocher, H. P.,
Greenberg, J. R.,
Qin, J.,
and Hinnebusch, A. G.
(1998)
Mol. Cell. Biol.
18,
4935-4946[Abstract/Free Full Text]
|
| 12.
|
Fletcher, C. M.,
Pestova, T. V.,
Hellen, C. U.,
and Wagner, G.
(1999)
EMBO J.
18,
2631-2637[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Korneeva, N. L.,
Lamphear, B. J.,
Hennigan, F. L.,
and Rhoads, R. E.
(2000)
J. Biol. Chem.
275,
41369-41376[Abstract/Free Full Text]
|
| 14.
|
Asano, K.,
Clayton, J.,
Shalev, A.,
and Hinnebusch, A. G.
(2000)
Genes Dev.
14,
2534-2546[Abstract/Free Full Text]
|
| 15.
|
Miyazaki, S.,
Rasmussen, S.,
Imatani, A.,
Diella, F.,
Sullivan, D. T.,
and Callahan, R.
(1999)
Gene (Amst.)
233,
241-247[Medline]
[Order article via Infotrieve]
|
| 16.
|
Yahalom, A.,
Kim, T. H.,
Winter, E.,
Karniol, B.,
von Arnim, A. G.,
and Chamovitz, D. A.
(2001)
J. Biol. Chem.
276,
334-340[Abstract/Free Full Text]
|
| 17.
|
Akiyoshi, Y.,
Clayton, J.,
Phan, L.,
Yamamoto, M.,
Hinnebusch, A. G.,
Watanabe, Y.,
and Asano, K.
(2001)
J. Biol. Chem.
276,
10056-10062[Abstract/Free Full Text]
|
| 18.
|
Guo, J.,
and Sen, G. C.
(2000)
J. Virol.
74,
1892-1899[Abstract/Free Full Text]
|
| 19.
|
Morris-Desbois, C.,
Bochard, V.,
Reynaud, C.,
and Jalinot, P.
(1999)
J. Cell Sci.
112,
3331-3342[Abstract]
|
| 20.
|
Cao, T.,
Duprez, E.,
Borden, K. L.,
Freemont, P. S.,
and Etkin, L. D.
(1998)
J. Cell Sci.
111,
1319-1329[Abstract]
|
| 21.
|
Crane, R.,
Craig, R.,
Murray, R.,
Dunand-Sauthier, I.,
Humphrey, T.,
and Norbury, C.
(2000)
Mol. Biol. Cell
11,
3993-4003[Abstract/Free Full Text]
|
| 22.
|
Bandyopadhyay, A.,
Matsumoto, T.,
and Maitra, U.
(2000)
Mol. Biol. Cell
11,
4005-4018[Abstract/Free Full Text]
|
| 23.
|
Yen, H. C.,
and Chang, E. C.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
14370-14375[Abstract/Free Full Text]
|
| 24.
|
Harlow, E.,
and Lane, D.
(1988)
Antibodies: A Laboratory Manual
, pp. 447-470, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 25.
|
Lennon, G.,
Auffray, C.,
Polymeropoulos, M.,
and Soares, M. B.
(1996)
Genomics
33,
151-152[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Green, S.,
Issemann, I.,
and Sheer, E.
(1988)
Nucleic Acids Res.
16,
369[Free Full Text]
|
| 27.
|
Bubeck, P.,
Winkler, M.,
and Bautsch, W.
(1993)
Nucleic Acids Res.
21,
3601-3602[Free Full Text]
|
| 28.
|
Jin, Y. J.,
Friedman, J.,
and Burakoff, S. J.
(1998)
J. Immunol.
161,
1743-1750[Abstract/Free Full Text]
|
| 29.
|
Hofmann, K.,
and Bucher, P.
(1998)
Trends Biochem. Sci.
23,
204-205[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Das, A. K.,
Cohen, P. W.,
and Barford, D.
(1998)
EMBO J.
17,
1192-1199[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Scheufler, C.,
Brinker, A.,
Bourenkov, G.,
Pegoraro, S.,
Moroder, L.,
Bartunik, H.,
Hartl, F. U.,
and Moarefi, I.
(2000)
Cell
101,
199-210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Murata, Y.,
and Wharton, R. P.
(1995)
Cell
80,
747-756[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Wreden, C.,
Verrotti, A. C.,
Schisa, J. A.,
Lieberfarb, M. E.,
and Strickland, S.
(1997)
Development
124,
3015-3023[Abstract]
|
| 34.
|
Sonoda, J.,
and Wharton, R. P.
(1999)
Genes Dev.
13,
2704-2712[Abstract/Free Full Text]
|
| 35.
|
Sonoda, J.,
and Wharton, R. P.
(2001)
Genes Dev.
15,
762-773[Abstract/Free Full Text]
|
| 36.
|
Zamore, P. D.,
Williamson, J. R.,
and Lehmann, R.
(1997)
RNA
3,
1421-1433[Abstract]
|
| 37.
|
Edwards, T. A.,
Pyle, S. E.,
Wharton, R. P.,
and Aggarwal, A. K.
(2001)
Cell
105,
281-289[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Burks, E. A.,
Bezerra, P. P.,
Le, H.,
Gallie, D. R.,
and Browning, K. S.
(2001)
J. Biol. Chem.
276,
2122-2131[Abstract/Free Full Text]
|
| 39.
|
MacDonald, J. I.,
Verdi, J. M.,
and Meakin, S. O.
(1999)
J. Mol. Neurosci.
13,
141-158[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Zhang, X. Pan, and J. W. B. Hershey
Individual Overexpression of Five Subunits of Human Translation Initiation Factor eIF3 Promotes Malignant Transformation of Immortal Fibroblast Cells
J. Biol. Chem.,
February 23, 2007;
282(8):
5790 - 5800.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Kransdorf, S. Z. Wang, S. Z. Zhu, T. B. Langston, J. W. Rupon, and G. D. Ginder
MBD2 is a critical component of a methyl cytosine-binding protein complex isolated from primary erythroid cells
Blood,
October 15, 2006;
108(8):
2836 - 2845.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. LeFebvre, N. L. Korneeva, M. Trutschl, U. Cvek, R. D. Duzan, C. A. Bradley, J. W. B. Hershey, and R. E. Rhoads
Translation Initiation Factor eIF4G-1 Binds to eIF3 through the eIF3e Subunit
J. Biol. Chem.,
August 11, 2006;
281(32):
22917 - 22932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Fraser, J. Y. Lee, G. L. Mayeur, M. Bushell, J. A. Doudna, and J. W. B. Hershey
The j-Subunit of Human Translation Initiation Factor eIF3 Is Required for the Stable Binding of eIF3 and Its Subcomplexes to 40 S Ribosomal Subunits in Vitro
J. Biol. Chem.,
March 5, 2004;
279(10):
8946 - 8956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Dunand-Sauthier, C. Walker, C. Wilkinson, C. Gordon, R. Crane, C. Norbury, and T. Humphrey
Sum1, a Component of the Fission Yeast eIF3 Translation Initiation Complex, Is Rapidly Relocalized During Environmental Stress and Interacts with Components of the 26S Proteasome
Mol. Biol. Cell,
May 1, 2002;
13(5):
1626 - 1640.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|